No Data
No Data
The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic Antibody Discovery
BAR HARBOR, Maine and MOUNTAIN VIEW, Calif., May 10, 2024 /PRNewswire/ -- The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotec
Decoding Gilead Sciences's Options Activity: What's the Big Picture?
Financial giants have made a conspicuous bullish move on Gilead Sciences. Our analysis of options history for Gilead Sciences (NASDAQ:GILD) revealed 9 unusual trades.Delving into the details, we found
Gilead Sciences (NASDAQ:GILD) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Gilead's Kite, Arcellx Share Phase 3 Trial Design for CAR-T Multiple Myeloma Asset
Express News | Arcellx Inc - Kite Expects Immagine-3 Trial to Start in Second Half of 2024
Express News | Arcellx Inc - Co, Kite Share Design of Global Phase 3 Trial, Immagine-3
No Data